...a non-exclusive, worldwide license to use Polyplus-transfection’s in vivo-jetPEI delivery technology for systemic delivery of SiRNAsense’s...
...development to treat melanoma metastasis. Financial terms were not disclosed. Polyplus-transfection S.A. , Strasbourg, France SiRNAsense A/S...